VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,550,750 | -5.4% | 169,110 | +5.8% | 2.26% | +5.6% |
| Q2 2023 | $4,812,451 | -7.8% | 159,829 | -0.9% | 2.14% | -9.5% |
| Q1 2023 | $5,218,993 | +35.7% | 161,329 | +20.2% | 2.37% | +35.3% |
| Q4 2022 | $3,845,456 | +30.5% | 134,175 | +9.8% | 1.75% | -3.3% |
| Q3 2022 | $2,947,000 | +4.8% | 122,175 | +18.9% | 1.81% | +14.3% |
| Q2 2022 | $2,812,000 | -12.2% | 102,719 | +23.0% | 1.58% | -1.7% |
| Q1 2022 | $3,203,000 | +284.5% | 83,531 | +221.0% | 1.61% | +313.9% |
| Q4 2021 | $833,000 | +48.5% | 26,022 | +36.8% | 0.39% | +33.2% |
| Q3 2021 | $561,000 | -41.4% | 19,022 | -44.8% | 0.29% | -39.7% |
| Q2 2021 | $958,000 | +12.4% | 34,485 | +5.0% | 0.48% | +0.2% |
| Q1 2021 | $852,000 | +58.4% | 32,838 | +119.8% | 0.48% | +50.0% |
| Q4 2020 | $538,000 | – | 14,938 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |